These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 30989336)

  • 21. [Fitness to drive in patients with cardiovascular implantable electronic devices].
    Mijic D; Lemke B; Bogossian H
    Herzschrittmacherther Elektrophysiol; 2019 Jun; 30(2):150-155. PubMed ID: 31073643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baroreceptor stimulation in a patient with preexisting subcutaneous implantable cardioverter defibrillator.
    Weipert KF; Andrick J; Chasan R; Gemein C; Most A; Hamm CW; Erkapic D; Schmitt J
    Pacing Clin Electrophysiol; 2018 Jan; 41(1):90-92. PubMed ID: 28543399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparameter Monitoring with a Wearable Cardioverter Defibrillator.
    Rohrer U; Manninger M; Zirlik A; Scherr D
    Sensors (Basel); 2021 Dec; 22(1):. PubMed ID: 35009564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmias in Patients with Implantable Devices.
    Sciarra L; Nesti M; Palamà Z; Marazzato J; Bagliani G; Leonelli FM; De Ponti R
    Card Electrophysiol Clin; 2019 Jun; 11(2):363-373. PubMed ID: 31084856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A; Kutyifa V; Vamvouris T; Moss AJ; Biton Y; Chen L; Storozynsky E; Wan C; Szymkiewicz SJ; Goldenberg I
    J Cardiovasc Electrophysiol; 2017 Jul; 28(7):778-784. PubMed ID: 28429542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients.
    Rorris FP; Charitos C
    Heart Fail Rev; 2021 Jul; 26(4):763-765. PubMed ID: 33404997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
    Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N
    Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].
    Stellbrink C; Hansky B; Meyer Zu Vilsendorf D
    Internist (Berl); 2018 Oct; 59(10):999-1010. PubMed ID: 30105398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency Care of Patients with Pacemakers and Defibrillators.
    Allison MG; Mallemat HA
    Emerg Med Clin North Am; 2015 Aug; 33(3):653-67. PubMed ID: 26226872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Device interaction between cardiac contractility modulation (CCM) and subcutaneous defibrillator (S-ICD).
    Trolese L; Faber T; Gressler A; Steinfurt J; Stuplich J; Jordan E; Bode C; Zehender M; Hilgendorf I
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3095-3098. PubMed ID: 34379359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication?
    Hofer D; Steffel J; Hürlimann D; Haegeli L; Lüscher TF; Duru F; Eriksson U; Krasniqi N
    J Interv Card Electrophysiol; 2017 Dec; 50(3):219-226. PubMed ID: 29177981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmortem interrogation of cardiac implantable electrical devices may clarify time and cause of death.
    Riesinger L; Fichtner S; Schuhmann CG; Estner HL; Czermak T; Graw M; Fischer F; Lackermair K
    Int J Legal Med; 2019 May; 133(3):883-888. PubMed ID: 30238160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiac remodelling and function after cardiovascular implantable electronic devices implantation].
    Stanek A; Lelakowski J; Matusik PT
    Pol Merkur Lekarski; 2019 Apr; 46(274):187-189. PubMed ID: 31099767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.